Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Nutrology
Review
DOI: 10.54448/ijn23102
Submitted: 01-27-2023
Published: 01-27-2023

Metabolic effects of coenzyme Q10, magnesium and vitamin D in cardiovascular diseases: a systematic review

Dr. Marcos Pires Clinic. Rua Inácio Ferreira Serrano 45. Terrazo di luna apto 3201 Brisamar, João Pessoa, Pernambuco, Brazil
Cardiovascular diseases Magnesium Vitamin D Coenzyme Q10 Metabolic processes

Abstract

Introduction: Cardiovascular diseases (CVD) are the main causes of death in the population. According to data from the World Health Organization for 2020, of the 20.8 million deaths from these diseases, 9.2 million are due to atherosclerotic coronary disease. In this context, the beneficial metabolic effects of magnesium, vitamin D, and coenzyme Q10 can be highlighted. Objective: It was to scientifically analyze, through clinical and experimental studies, the influence of the three elements Magnesium, Vitamin D, and Coenzyme Q10 concerning cardiovascular diseases and metabolic syndrome, highlighting the improvement of metabolic disorders and heart failure. Methods: The systematic review rules of the PRISMA Platform were followed. The research was carried out from September to November 2022 in Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. Results and Conclusion: A total of 154 articles were found, and 80 articles were evaluated and 78 were included in this systematic review. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 18 studies with a high risk of bias and 26 studies that did not meet GRADE. Most studies showed homogeneity in their results, with I2 =95.7% >50%. It was concluded that magnesium plays a fundamental role in glucose metabolism, insulin, and glycemic homeostasis, in the synthesis of adenosine triphosphate, proteins, and nucleic acids. However, further studies are needed to better clarify the role of magnesium in the prevention and treatment of cardiovascular diseases, especially concerning higher concentrations and increased treatment time. Vitamin D plays important roles in innate and adaptive immune responses, cell cycle, and metabolic processes, evidenced by the reported relationship between its deficiency and the prevalence of immune-mediated disorders, cancer, and cardiometabolic diseases. Coenzyme Q10 exerts an important protective antioxidant action. Clinical studies carried out showed that pathologies such as acute myocardial infarction, arterial hypertension, myopathies induced by statins, physical fatigue inherent to physical exercise, male infertility, pre-eclampsia, Parkinson's disease, periodontal diseases, and migraines had low plasma concentrations of Q10. In addition, Coenzyme Q10 reduces the amount of lipid peroxide found in atherosclerotic lesions. Thus, Q10 protects the lipids present in cell membranes, as well as plasma lipoproteins.

Metrics

Metrics Loading ...

References

  1. Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, Carty C, Chaput JP, Chastin S, Chou R, Dempsey PC, DiPietro L, Ekelund U, Firth J, Friedenreich CM, Garcia L, Gichu M, Jago R, Katzmarzyk PT, Lambert E, Leitzmann M, Milton K, Ortega FB, Ranasinghe C, Stamatakis E, Tiedemann A, Troiano RP, van der Ploeg HP, Wari V, Willumsen JF. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020 Dec;54(24):1451-1462. doi: 10.1136/bjsports-2020-102955.
  2. Mehta A, Vasquez N, Ayers CR, Patel J, Hooda A, Khera A, Blumenthal RS, Shapiro MD, Rodriguez CJ, Tsai MY, Sperling LS, Virani SS, Blaha MJ, Joshi PH. Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk. J Am Coll Cardiol. 2022 Mar 1;79(8):757-768. doi: 10.1016/j.jacc.2021.11.058.
  3. Dawson LP, Lum M, Nerleker N, Nicholls SJ, Layland J. Coronary Atherosclerotic Plaque Regression: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 Jan 4;79(1):66-82. doi: 10.1016/j.jacc.2021.10.035.
  4. Peter J. Joris, Jogchum Plat, Stephan JL, Bakker, Ronald P. Mensink. Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults. Scientific Reports 2017, 7: 106.
  5. Baker WL. Treating arrhythmias with adjunctive magnesium: identifying future research directions. Eur Heart J Cardiovasc Pharmacother. 2017; 1;3(2):108117.
  6. Yu L, Li H, Wang SX. Serum Magnesium and Mortality in Maintenance Hemodialysis Patients. Blood Purif. 2017;43(13): 3136.
  7. Amorim AG, Tirapegui J. Aspectos atuais da relação entre exercício físico, estresse oxidativo e magnésio. Rev Nutr, 2008; 21(5):563-75.
  8. Baaij JHF, Hoenderop JGJ, Bindels RJM. Regulation of magnesium balance: lessons learned from human genetic disease. Clin Kidney J, 2012; 5(1):i15-i24.
  9. Blanchard A, Vargas-Poussou R. Désordres de la magnésémie. Nephrol Ther, 2012; 8(6):482-91.
  10. Elin RJ. Assessment of magnesium status for diagnosis and therapy. Magnes Res, 2010; 23(4):194-8.
  11. Hata A, Doi Y, Ninomiya T, Mukai N, Hirakawa Y, Hata J, et al. Magnesium intake decreases Type 2 diabetes risk through the improvement of insulin resistance and inflammation: the Hisayama Study. Diabet Med, 2013; 30(12):1487-94.
  12. Houillier P. Mechanisms and regulation of renal magnesium transport. Annu Rev Physiol, 2014; 76:411-30. Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J, 2012; 5(1):i3–i14.
  13. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69(5):842–56.
  14. Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr 2002;76(1):187–92.
  15. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005;135(2):317–22.
  16. Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007;85(3):860–8.
  17. Tóth Š, Šajty M, Pekárová T, Mughees A, Štefanič P, Katz M, Spišáková K, Pella J, Pella D. Addition of omega-3 fatty acid and coenzyme Q10 to statin therapy in patients with combined dyslipidemia. J Basic Clin Physiol Pharmacol. 2017.
  18. Kumar A, Kaur H, Devi P, Mohan V. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacology & Therapeutics, 2010, 124: 259-268.
  19. Littaru G, Langsjoen P. Coenzyme Q10 and statins: Biochemical and clinical implications. Mitochondrion, 2007, 7: S168-S174.
  20. Littaru G, Langsjoen P. Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Molecular Biotechnology, 2007, 37(1):31-37. Mitochondrion, 2007, 7: S168- S174.
  21. Fang, X. et al. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a doseresponse meta-analysis of prospective cohort studies. BMC Med. 2016; 14, 210.
  22. Del Gobbo, L. C. et al. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am. J. Clin. Nutr. 2013; 98, 160– 173.
  23. Joosten, M. M. et al. Urinary and plasma magnesium and risk of ischemic heart disease. Am. J. Clin. Nutr. 2013; 97, 1299–1306.
  24. Joris, P. J., Plat, J., Bakker, S. J. & Mensink, R. P. Long-term magnesium supplementation improves arterial stiffness in overweight and obese adults: results of a randomized, double-blind, placebo-controlled intervention trial. Am. J. Clin. Nutr. 2016; 103, 1260–1266.
  25. Laurent, S. et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J. 2006; 27, 2588–2605.
  26. Wilkinson, I. B. et al. Nitric oxide regulates local arterial distensibility in vivo. Circulation. 2002; 105, 213–217.
  27. Guerrero-Romero, F. et al. Oral magnesium supplementation improves insulin sensitivity in nondiabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab. 2004; 30, 253–258.
  28. Paolisso, G. et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am. J. Clin. Nutr. 1992; 55, 1161–1167.
  29. Marken, P. A. et al. Effects of magnesium oxide on the lipid profile of healthy volunteers. Atherosclerosis. 1989; 77, 37–42.
  30. Chacko, S. A. et al. Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in overweight individuals. Am. J. Clin. Nutr. 2011; 93, 463–473.
  31. Cosaro, E. et al. Effects of magnesium supplements on blood pressure, endothelial function and metabolic parameters in healthy young men with a family history of metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 2014; 24, 1213–1220.
  32. Mortazavi, M. et al. Effect of magnesium supplementation on carotid intima-media thickness and flow-mediated dilatation among hemodialysis patients: a double-blind, randomized, placebocontrolled trial. Eur. Neurol.2013; 69, 309–316.
  33. Shechter, M. et al. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation. 2000; 102, 2353–2358.
  34. Ellins, E. A. & Halcox, J. P. Where are we heading with noninvasive clinical vascular physiology? Why and how should we assess endothelial function? Cardiol. Res. Pract 2011, 870132.
  35. Poredos, P. & Jezovnik, M. K. Testing endothelial function and its clinical relevance. J. Atheroscler. Thromb. 2013; 20, 1–8.
  36. Deanfield, J. E., Halcox, J. P. & Rabelink, T. J. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007; 115, 1285–1295.
  37. Cohn, J. N., Quyyumi, A. A., Hollenberg, N. K. & Jamerson, K. A. Surrogate markers for cardiovascular disease: functional markers. Circulation. 2004; 109, IV31–IV46.
  38. Beijers, H. J. et al. Higher central fat mass and lower peripheral lean mass are independent determinants of endothelial dysfunction in the elderly: the Hoorn study. Atherosclerosis. 2014; 233, 310–318.
  39. Despres, J. P. & Lemieux, I. Abdominal obesity and metabolic syndrome. Nature. 2006; 444, 881–887.
  40. Ras, R. T., Streppel, M. T., Draijer, R. & Zock, P. L. Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int. J. Cardiol.2013; 168, 344–351.
  41. Seelig, M. Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations-magnesium and chloride loss in refractory potassium repletion. Am. J. Cardiol.1989; 63, 4G–21G.
  42. Turgut, F. et al. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int. Urol. Nephrol. 2008; 40, 1075–1082.
  43. Lorenz, M. W. et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and metaanalysis. Circulation. 2007; 115, 459–467.
  44. Calder, P. C. et al. A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies. Br. J. Nutr. 2013, 109, S1–S34.
  45. Cunha, A. R., Umbelino, B., Correia, M. L. & Neves, M. F. Magnesium and vascular changes in hypertension. Int. J. Hypertens. 2012, 754250.
  46. Song, Y., He, K., Levitan, E. B., Manson, J. E. & Liu, S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized doubleblind controlled trials. Diabet. Med. 2006; 23, 1050–1056.
  47. Simental-Mendia, L. E., Sahebkar, A., Rodriguez-Moran, M. & Guerrero-Romero, F. A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol. Res.2016; 111, 272–282.
  48. Heil, W. & Ehrhardt, V. Reference ranges for adults and children. Pre-analytical considerations in Roche Diagnostics 9th Edition (2008).
  49. Moslehi, N., Vafa, M., Rahimi-Foroushani, A. & Golestan, B. Effects of oral magnesium supplementation on inflammatory markers in middle-aged overweight women. J. Res. Med. Sci. 2012; 17, 607–614.
  50. Van Mil, A. C. et al. Impact of volunteer-related and methodology-related factors on the reproducibility of brachial artery flowmediated vasodilation: analysis of 672 individual repeated measurements. J. Hypertens. 2016; 34, 1738–1745.
  51. Maier, J. A., Malpuech-Brugère, C., Zimowska, W., Rayssiguier, Y. & Mazur, A. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and trombosis. Biochim. Biophys. Acta. 2004; 1689, 13–21.
  52. Maier, J. A. Endothelial cells and magnesium: implications in atherosclerosis. Clin. Sci. (Lond.)2012; 122, 397–407.
  53. Santulli, G. MicroRNAs and Endothelial (Dys) Function. J. Cell Physiol. 2016; 231, 1638–1644.
  54. Sorriento, D. et al. Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo. Hypertension. 2012; 60, 129–136.
  55. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117(4):503–11.
  56. Salehpour A, Shidfar F, Hosseinpanah F, Vafa M, Razaghi M, Hoshiarrad A, et al. Vitamin D 3 and the risk of CVD in overweight and obese women: a randomized controlled trial. Br J Nutr 2012;108(10):1866–73. S0007114512000098.
  57. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 2010;39(2):365–79.
  58. Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol 2006;92(1):60–4.
  59. Michos ED, Melamed ML. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 2008;11(1):7–12. http://dx.doi.org/10.1097/MCO.0b013e3282f2f4dd.
  60. Vaidya A. Vitamin D and cardio-metabolic disease. Metabolism 2013;62(12):1697.
  61. Wolden-Kirk H, Overbergh L, Christesen HT, Brusgaard K, Mathieu C. Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol 2011;347(1): 106–20..
  62. Kim HJ, Kang CK, Park H, Lee MG. Effects of vitamin D supplementation and circuit training on indices of obesity. and insulin resistance in T2D and vitamin D deficient elderly women. J Exerc Nutr Biochem 2014;18(3):249.
  63. Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr 2004;79(5):820–5.
  64. Schuch NJ, Garcia VC, Martini LA. Vitamin D and endocrine diseases. Arq Bras Endocrinol Metab 2009;53(5):625–33.
  65. Norman PE, Powell JT. Vitamin D and cardiovascular disease. Circ Res 2014;114(2):379–93.
  66. Herrmann M, Sullivan DR, Veillard A, McCorquodale T, Straub IR, Scott R, et al. Serum 25- Hydroxy vitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care 2014;38(3): 521–8.
  67. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115(5):1111– 9.
  68. Cani PD, Delzenne NM. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care 2007;10(6):729–34.. 0b013e3282efdebb.
  69. Caricilli AM, Picardi PK, de Abreu LL, Ueno M, Prada PO, Ropelle ER, et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol 2011; 9(12):e1001212.
  70. Moraes ACF, Silva IT, Almeida-Pititto B, Ferreira SRG. Microbiota intestinal e risco cardiometabólico: mecanismos e modulação dietética. Arq Bras Endocrinol Metab 2014;58(4): 317–27.
  71. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98(8):731–3.
  72. Calder PC, Ahluwalia N, Albers R, Bosco N, Bourdet-Sicard R, Haller D, et al. A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies. Br J Nutr 2013;109(S1):S1–S34.
  73. Almeida-Pititto B, Ribeiro-Filho FF, Bittencourt MS, Lotufo PA, Bensenor I, Ferreira SR. Usefulness of circulating E-selectin to early detection of the atherosclerotic process in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Diabetol Metab Syndr 2016;8(19).
  74. Littaru G, Langsjoen P. Clinical aspects of coenzyme Q10: an update. Nutrition, 2010, 26(3): 250-254.
  75. Mas E, Mori T. Coenzyme Q10 and statin myalgia: What is the evidence? Current Atherosclerosis Reports. 2010, 12(6): 407-413.
  76. Pepe S, Marasco S, Haas S, Sheeran F, Krum H, Rosenfeldt F. Coenzyme Q10 in cardiovascular disease. Mitochondrion. 2007, 7(S):154-167.
  77. Prakash S, Sunitha J, Hans M. Role of coenzyme Q10 as an antioxidant and bioenergizer in periodontal diseases. Indian Journal of Pharmacology. 2010, 42(6): 334-337.
  78. Michley L, Allen J, Bradley R. Coenzyme Q10 deficience in patients with Parkinson’ disease. Journal of the Neurological Sciences. 2012, 318: 72-75.

How to Cite

Meira Júnior, M. A. P. (2023). Metabolic effects of coenzyme Q10, magnesium and vitamin D in cardiovascular diseases: a systematic review. International Journal of Nutrology, 16(1). https://doi.org/10.54448/ijn23102